Ignite Creation Date:
2024-05-06 @ 5:40 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05396833
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2022-05-24
Brief Title:
Study of Tuvusertib M1774 in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor DDRiver Solid Tumors 320
Sponsor:
EMD Serono Research Development Institute Inc
Organization:
EMD Serono
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic or Locally Advanced Unresectable Solid Tumors |